Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 29;11(4):458.
doi: 10.3390/antibiotics11040458.

Stability Studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy

Affiliations

Stability Studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy

Guillaume Loeuille et al. Antibiotics (Basel). .

Abstract

The use of continuous infusion to improve the therapeutic efficacy of time-dependent antibiotics has been demonstrated. There is still a lack of data to safely perform these continuous infusions. The objectives in this study were to evaluate the stability by using stability-indicating methods (High-Performance Liquid Chromatography) of 16 antibiotics in concentrated solutions, especially for administration in intensive care units and solutions in elastomeric diffusers at 37 °C for outpatient parenteral antimicrobial therapy. The solutions were considered stable if the percentage of the drug was ≥90%, and the colour and clearness remained unchanged. In syringes, the stability data vary from 4 to 8 h (h) for meropenem in Dextrose 5% (D5W) and Normal Saline (NS), respectively, 6 h for cefotaxime, 12 h for cefoxitin, and 24 h for aztreonam, cefazolin, cefepime, cefiderocol, ceftazidime/avibactam, ceftolozane/tazobactam in NS and D5W, and in water for injection for cloxacillin. A stability period of 48 h has been validated for vancomycin (D5W), aztreonam, and piperacillin/tazobactam. Cefoxitin, cefazolin, cefepime, cefotaxime, cloxacillin, and piperacillin are unstable for diffuser administration. In diffusers, stability times vary from 6 h for cefiderocol, 8 h for ceftazidime, 12 h for ceftazidime/avibactam and ceftolozane/tazobactam (NS), 24 h for temocillin (NS) and piperacillin/tazobactam (D5W), up to 48 h for aztreonam and vancomycin. Solutions stored at 37 °C are less stable and allow the administration of seven antibiotics using diffusers.

Keywords: antibiotic; continuous infusion; intensive care unit; outpatient parenteral antimicrobial therapy; stability.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Examples of chromatograms of piperacillin/tazobactam (300/37.5 µg/mL) (A); aztreonam (100 µg/mL) (B); cefotaxime (100 µg/mL) (C); and temocillin R and S (150 µg/mL) (D), obtained immediately after reconstitution in Normal Saline solution.

References

    1. Mouton J.W., Punt N., Vinks A.A. Concentration-Effect Relationship of Ceftazidime Explains Why the Time above the MIC Is 40 Percent for a Static Effect In Vivo. Antimicrob. Agents Chemother. 2007;51:3449–3451. doi: 10.1128/AAC.01586-06. - DOI - PMC - PubMed
    1. Lee Y.R., Miller P.D., Alzghari S.K., Blanco D.D., Hager J.D., Kuntz K.S. Continuous Infusion Versus Intermittent Bolus of Beta-Lactams in Critically Ill Patients with Respiratory Infections: A Systematic Review and Meta-Analysis. Eur. J. Drug Metab. Pharmacokinet. 2018;43:155–170. doi: 10.1007/s13318-017-0439-5. - DOI - PubMed
    1. De Jongh R., Hens R., Basma V., Mouton J.W., Tulkens P.M., Carryn S. Continuous versus Intermittent Infusion of Temocillin, a Directed Spectrum Penicillin for Intensive Care Patients with Nosocomial Pneumonia: Stability, Compatibility, Population Pharmacokinetic Studies and Breakpoint Selection. J. Antimicrob. Chemother. 2008;61:382–388. doi: 10.1093/jac/dkm467. - DOI - PubMed
    1. Roberts J.A., Abdul-Aziz M.-H., Davis J.S., Dulhunty J.M., Cotta M.O., Myburgh J., Bellomo R., Lipman J. Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-Analysis of Individual Patient Data from Randomized Trials. Am. J. Respir. Crit. Care Med. 2016;194:681–691. doi: 10.1164/rccm.201601-0024OC. - DOI - PubMed
    1. Flannery A., Bissell B., Thompson Bastin M., Morris P., Neyra J. Continuous versus Intermittent Infusion of Vancomycin and the Risk of Acute Kidney Injury in Critically Ill Adults: A Systematic Review and Meta-Analysis. Crit Care Med. 2020;48:912–918. doi: 10.1097/CCM.0000000000004326. - DOI - PubMed

LinkOut - more resources